Ken Kelly

Nessuna posizione attualmente

Consumer Services

Finance

Profilo

Mr. Kelly currently serves on the Boards of several biotech and medical device companies (CODA Genomics (an LSA company) EndoNav, Halozyme Therapeutics, MPEX Pharmaceuticals, NovaShunt, Solus Biosystems, and StemCor Systems).
He also provides strategic advice to EndoVx, ForteBio, and others.
Previously, he was the founder/CEO and Chairman at IntraBiotics Pharmaceuticals, which he took public in 2000.
He participated in the startup financing of over two dozen biotech and medical device companies while a General Partner at Latterell Venture Partners (LVP) and earlier as a Senior Associate at Institutional Venture Partners (IVP).
He was also a consultant for McKinsey & Company and a scientist at Integrated Genetics (acquired by Genzyme).
He has an MBA from Stanford and a BA in biochemical sciences from Harvard.

Precedenti posizioni note di Ken Kelly

Società	Posizione	Fine
Life Science Angels Life Science Angels Investment ManagersFinance Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California.	Direttore/Membro del Consiglio	30/06/2007

Vedi nel dettaglio l'esperienza di Ken Kelly

Formazione di Ken Kelly

Stanford University	Masters Business Admin
Harvard University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private